News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
196,468 Results
Type
Article (32872)
Company Profile (21)
Press Release (163575)
Multimedia
Podcasts (4)
Webinars (10)
Section
Business (60049)
Career Advice (637)
Deals (4954)
Drug Delivery (12)
Drug Development (25296)
Employer Resources (41)
FDA (3826)
Job Trends (3879)
News (92748)
Policy (5369)
Tag
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (1)
2024 Genetown Standard (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (2)
2026 Biotech Bay Standard (1)
Academia (2424)
Academic (1)
Accelerated approval (2)
Adcomms (7)
Allergies (20)
Alliances (13731)
ALS (29)
Alzheimer's disease (532)
Antibody-drug conjugate (ADC) (27)
Approvals (3850)
Artificial intelligence (63)
Autoimmune disease (1)
Automation (4)
Bankruptcy (26)
Best Places to Work (3195)
BIOSECURE Act (4)
Biosimilars (9)
Biotechnology (17)
Bladder cancer (24)
Brain cancer (8)
Breast cancer (90)
Cancer (655)
Cardiovascular disease (42)
Career advice (556)
Career pathing (12)
CAR-T (43)
Cell therapy (122)
Cervical cancer (6)
Clinical research (19704)
Collaboration (207)
Compensation (22)
Complete response letters (2)
COVID-19 (1257)
CRISPR (17)
C-suite (150)
Cystic fibrosis (24)
Data (772)
Decentralized trials (1)
Denatured (3)
Depression (7)
Diabetes (59)
Diagnostics (1965)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (28)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (21)
Earnings (9052)
Editorial (5)
Employer branding (4)
Employer resources (37)
Events (20688)
Executive appointments (483)
FDA (4106)
Featured Employer (9)
Frontotemporal dementia (4)
Funding (233)
Gene editing (41)
Generative AI (5)
Gene therapy (88)
GLP-1 (146)
Government (1097)
Grass and pollen (1)
Guidances (9)
Healthcare (5602)
Huntington's disease (3)
IgA nephropathy (8)
Immunology and inflammation (13)
Indications (9)
Infectious disease (1297)
Inflammatory bowel disease (46)
Inflation Reduction Act (1)
Influenza (20)
Intellectual property (23)
Interviews (120)
IPO (2033)
IRA (6)
Job creations (769)
Job search strategy (494)
Kidney cancer (5)
Labor market (7)
Layoffs (52)
Leadership (2)
Legal (879)
Liver cancer (25)
Lung cancer (86)
Lymphoma (50)
Machine learning (2)
Management (11)
Manufacturing (73)
MASH (24)
Medical device (3767)
Medtech (3769)
Mergers & acquisitions (3001)
Metabolic disorders (125)
Multiple sclerosis (20)
NASH (5)
Neurodegenerative disease (28)
Neuropsychiatric disorders (1)
Neuroscience (663)
NextGen: Class of 2025 (2061)
Non-profit (1802)
Northern California (698)
Now hiring (8)
Obesity (41)
Opinion (41)
Ovarian cancer (31)
Pain (15)
Pancreatic cancer (27)
Parkinson's disease (38)
Partnered (5)
Patents (47)
Patient recruitment (37)
Peanut (12)
People (33959)
Pharmaceutical (4)
Pharmacy benefit managers (1)
Phase I (6258)
Phase II (8985)
Phase III (6026)
Pipeline (225)
Policy (22)
Postmarket research (1000)
Preclinical (3214)
Press Release (34)
Prostate cancer (28)
Psychedelics (8)
Radiopharmaceuticals (79)
Rare diseases (92)
Real estate (1751)
Recruiting (21)
Regulatory (3866)
Reports (7)
Research institute (1411)
Resumes & cover letters (76)
Rett syndrome (2)
RNA editing (1)
RSV (3)
Schizophrenia (9)
Series A (39)
Series B (25)
Service/supplier (2)
Sickle cell disease (16)
Southern California (548)
Spinal muscular atrophy (38)
Sponsored (12)
Startups (1296)
Stomach cancer (2)
Supply chain (6)
Tariffs (3)
The Weekly (1)
United States (5507)
Vaccines (227)
Venture capitalists (1)
Weight loss (24)
Women's health (6)
Worklife (2)
Date
Today (55)
Last 7 days (230)
Last 30 days (672)
Last 365 days (8096)
2025 (2439)
2024 (8612)
2023 (10705)
2022 (13362)
2021 (15275)
2020 (14880)
2019 (14163)
2018 (10572)
2017 (10021)
2016 (10166)
2015 (11492)
2014 (8871)
2013 (8571)
2012 (8646)
2011 (8685)
2010 (7662)
Location
Africa (338)
Alabama (13)
Alaska (3)
Arizona (41)
Arkansas (7)
Asia (11995)
Australia (2814)
California (1474)
Canada (448)
China (118)
Colorado (68)
Connecticut (69)
Delaware (31)
Europe (33231)
Florida (174)
Georgia (52)
Idaho (12)
Illinois (137)
India (4)
Indiana (69)
Iowa (2)
Japan (51)
Kansas (16)
Kentucky (5)
Louisiana (3)
Maine (38)
Maryland (184)
Massachusetts (1019)
Michigan (77)
Minnesota (76)
Mississippi (1)
Missouri (23)
Montana (6)
Nebraska (6)
Nevada (15)
New Hampshire (9)
New Jersey (403)
New Mexico (11)
New York (430)
North Carolina (309)
North Dakota (3)
Northern California (698)
Ohio (78)
Oklahoma (6)
Oregon (9)
Pennsylvania (279)
Puerto Rico (1)
Rhode Island (13)
South America (360)
South Carolina (4)
Southern California (548)
Tennessee (30)
Texas (218)
Utah (46)
Virginia (38)
Washington D.C. (20)
Washington State (159)
West Virginia (1)
Wisconsin (14)
196,468 Results for "munich technical university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
ITM, Helmholtz Munich and University Hospital Münster Announce First Patient Dosed in Phase I Investigator-Initiated Glioblastoma Trial
The Departments of Neurosurgery and Nuclear Medicine at the University Hospital Münster, Helmholtz Munich, and ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, announced that the first patient has been dosed in an investigator-initiated trial with ITM’s radiopharmaceutical drug candidate, ITM-31 for the potential use in glioblastoma patients.
April 23, 2024
·
4 min read
Layoffs
Novartis Cuts MorphoSys Sites in Boston, Munich, Affecting 330 Jobs
The closures follow Novartis’s acquisition of MorphoSys earlier this year.
December 19, 2024
·
1 min read
·
Annalee Armstrong
Press Releases
BioNxt Accelerates R&D with Move to Gen-Plus Laboratory in Munich, Germany, Expanding Drug Delivery Research Capabilities
January 21, 2025
·
5 min read
Press Releases
Phio Pharmaceuticals Announces Podium Presentations on INTASYL siRNA Lead Product Candidates PH-762 and PH-894
To be presented at 11th Annual Immunotherapy of Cancer (ITOC) Conference in Munich, Germany
April 3, 2025
·
4 min read
Business
Blue Earth Diagnostics Announces Data-sharing Agreement with Siemens Healthineers and the University Hospital of Technical University of Munich (TUM) for 18F-rhPSMA-7.3
Blue Earth Diagnostics today announced the signing of a data-sharing agreement with Siemens Healthineers and the University Hospital of the Technical University of Munich (TUM) for anonymized 18 F-rhPSMA-7.3 clinical data and images.
October 18, 2022
·
6 min read
Pharm Country
Laxxon Medical to Attend BIO-Europe Munich 2023
Laxxon Medical announced its participation in the 29th annual BIO-Europe Convention, taking place November 6-8, 2023 in Munich, Germany.
November 6, 2023
·
2 min read
Business
Immunome Appoints Phil Tsai as Chief Technical Officer
Immunome, Inc. today announced the appointment of Phil Tsai, PhD, as Chief Technical Officer.
June 27, 2024
·
5 min read
Press Releases
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
February 4, 2025
·
10 min read
Press Releases
Bluejay Therapeutics Appoints Mary Cromwell as Senior Vice President and Head of Technical Operations
February 13, 2025
·
2 min read
Pharm Country
Actinium Pharmaceuticals to Attend Bio-Europe Munich 2023
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced that it will be attending Bio-Europe, the largest biopharmaceutical industry partnering event in Europe, taking place November 6 – 8, 2023 in Munich, Germany.
November 2, 2023
·
2 min read
1 of 19,647
Next
